Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer.
Journal Information
Full Title: Investig Clin Urol
Abbreviation: Investig Clin Urol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICTS OF INTEREST: The authors have nothing to disclose."
Funding Disclosure
Evidence found in paper:
"FUNDING: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1A2C1004046) (2021R1G1A1092985) (2022R1I1A3069482) (2023R1A2C3003807), and by the Korean Fund for Regenerative Medicine (KFRM) grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Health & Welfare) (23A0206L1)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025